MCISX | NWXUX | MCISX / NWXUX | |
Total Expense Ratio | 2.10 | 0.90 | 233% |
Annual Report Gross Expense Ratio | 2.91 | 1.05 | 277% |
Fund Existence | 18 years | 9 years | - |
Gain YTD | 30.474 | 26.449 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.01B | 236M | 1,701% |
Annual Yield % from dividends | 0.62 | 8.51 | 7% |
Returns for 1 year | 32.22 | 25.89 | 124% |
Returns for 3 years | 52.14 | 49.87 | 105% |
Returns for 5 years | 37.47 | 36.91 | 102% |
Returns for 10 years | 68.67 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VGIAX | 112.01 | 0.89 | +0.80% |
Vanguard Growth & Income Adm | |||
ADECX | 17.43 | 0.09 | +0.52% |
Columbia Large Cap Value C | |||
BIPIX | 40.27 | 0.08 | +0.20% |
ProFunds Biotechnology UltraSector Inv | |||
RGYTX | 9.86 | N/A | N/A |
Russell Inv Multi-Strategy Income M | |||
FRLCX | 13.49 | -0.12 | -0.88% |
Nuveen Real Estate Securities C |